Alyeska Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-41,476
| Closed | -$39.9M | – | 614 |
|
|
2024
Q1 | $39.9M | Buy |
+41,476
| New | +$39.9M | 0.25% | 139 |
|
|
2023
Q3 | – | Sell |
-112,238
| Closed | -$80.6M | – | 577 |
|
|
2023
Q2 | $80.6M | Buy |
+112,238
| New | +$80.6M | 0.6% | 46 |
|
|
2023
Q1 | – | Sell |
-72,964
| Closed | -$52.6M | – | 511 |
|
|
2022
Q4 | $52.6M | Buy |
+72,964
| New | +$52.6M | 0.54% | 58 |
|
|
2021
Q1 | – | Sell |
-742
| Closed | -$358K | – | 798 |
|
|
2020
Q4 | $358K | Sell |
742
-9,258
| -93% | -$4.47M | 0.01% | 458 |
|
|
2020
Q3 | $5.6M | Sell |
10,000
-33,692
| -77% | -$18.9M | 0.09% | 243 |
|
|
2020
Q2 | $27.2M | Buy |
+43,692
| New | +$27.2M | 0.41% | 73 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 504 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 531 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 534 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 499 |
|
|
2013
Q4 | – | Sell |
-30,000
| Closed | -$9.39M | – | 316 |
|
|
2013
Q3 | $9.39M | Buy |
30,000
+10,000
| +50% | +$3.13M | 0.38% | 68 |
|
|
2013
Q2 | $4.5M | Buy |
+20,000
| New | +$4.5M | 0.22% | 114 |
|